• Join
  • Login
  • Contact

Search abstracts / presentations

Design, Synthesis, and Biological Evaluation of Thienopyrimidine Derivatives as Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes

  • In: Poster Presentation
  • At: Stockholm (Sweden) (2017)
  • Type: Poster
  • Poster code: P-A-047-Monday
  • By: WANG, Jiang (Shanghai Institute of Materia Medica, shanghai, China)
  • Co-author(s): Jiang Wang: Shanghai Institute of Materia Medica, shanghai, China
    Hong liu: Shanghai Institute of Materia Medica, shanghai, China
  • Abstract:


    Type 2 diabetes mellitus (T2DM) is the most common form of the diabetes disease, accounting for about 90-95% of all diagnosed North American cases of diabetes. DPP-4 inhibitors have emerged as a new therapeutic option to treat type 2 diabetes.


    To discovery and development of novel DPP-4 inhibitors as a new therapeutic metord for the


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses